![](https://endpts.com/wp-content/uploads/2022/06/Karim-Mikhail-Amarin-tile.jpg)
Karim Mikhail, Amarin CEO
Amarin CFO resigns amid cost-cutting measures, staff reduction of 40%
A year after a Supreme Court opinion put the final nail in the coffin for Amarin’s fish-oil heart drug, the biotech is making some …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.